跳至主要内容
临床试验/ISRCTN15709915
ISRCTN15709915进行中(未招募)未知

The combined use of serum neurotensin and IL-8 as screening markers for colorectal cancer and adenomas. A prospective study.

niversity Hospitals of Morecambe Bay0 个研究点目标入组 500 人开始时间: 2019年3月4日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • 1. Aged over 50 years
  • 2. Referred for colonoscopy for any suspected indication

排除标准

  • 1. Need for emergency surgery
  • 2. Presence of inflammatory bowel disease
  • 3. Known history of inherited colorectal cancer
  • 4. History of cancer in another primary site
  • 5. Presence of liver metastases (since neurotensin is metabolized in the liver)
  • 6. Negative previous colonoscopy for cancer
  • 7. Haemolysis in serum samples
  • 8. Informed consent not signed or patient withdrew consent
  • 9. Persons who will not have the capacity to decide for themselves, who are unable to represent their own interests or are particularly susceptible to coercion

研究者

发起方
niversity Hospitals of Morecambe Bay

相似试验